Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05863754 · ClinicalTrials.gov registry record · NA

Grasp-Release Assessment of a Networked Neuroprosthesis Device

A NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, sponsored by MetroHealth Medical Center.

Recruiting
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT05863754 is a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical that is actively recruiting participants, run by MetroHealth Medical Center. The registered enrollment target is 13 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05863754, a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, is actively recruiting participants, sponsored by MetroHealth Medical Center.

RECRUITING
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.

Interventions

  • DEVICE Networked Neuroprosthesis Device

Study Locations (1)

Ohio

  • MetroHealth Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2022-01-23
Est. Completion 2028-12-01
Phase NA

Sponsor

MetroHealth Medical Center

76 total trials

What the Registry Record Tells You About NCT05863754

The ClinicalTrials.gov registry entry for NCT05863754 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (79% lower). The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Networked Neuroprosthesis Device is the first listed.

NCT05863754 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05863754 about?

NCT05863754 is a clinical study titled "Grasp-Release Assessment of a Networked Neuroprosthesis Device". The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.

What is the current status of trial NCT05863754?

This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2022-01-23. Estimated completion is 2028-12-01.

What conditions does trial NCT05863754 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Injury Cervical, Spinal Cord Injury at C5-C7 Level.

What interventions are being tested in trial NCT05863754?

The interventions under investigation include: Networked Neuroprosthesis Device (DEVICE).

Who is sponsoring clinical trial NCT05863754?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05863754 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.